- Zacks•2 days ago
The Centers for Medicare & Medicaid Services published an article clarifying the criteria for coverage of its DexCom (DXCM) G5 Mobile CGM system for patients with diabetes and on intensive insulin therapy.
- Business Wire•5 days ago
Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy
DexCom, Inc. , the leader in continuous glucose monitoring for people with diabetes, is pleased to announce that the U.S. Centers for Medicare & Medicaid Services has published an article clarifying criteria for coverage and coding of the Dexcom G5 Mobile system, the only therapeutic CGM under this CMS classification.
- Business Wire•6 days ago
DexCom Schedules First Quarter 2017 Earnings Release and Conference Call for May 2, 2017 at 4:30 p.m. Eastern Time
DexCom, Inc. today announced that it plans to release its first quarter 2017 financial results after market close on Tuesday, May 2, 2017. Management will hold a conference call to review the company's first quarter 2017 performance starting at 4:30 p.m.
DXCM : Summary for DexCom, Inc. - Yahoo Finance
DexCom, Inc. (DXCM)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||85.03 x 100|
|Ask||85.07 x 300|
|Day's Range||83.87 - 86.24|
|52 Week Range||57.68 - 96.38|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-108.19|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|